Lymphoma Canada is earnest about our role as "The Patient Voice". We strive to ensure that decision-makers understand the needs of the lymphoma community and how their decisions impact those affected by lymphoma. Through our work on health technology assessment, private payer reimbursement, biosimilar therapies and other topics that have immediate and long-term consequences for patients and their families, we question the status quo, offer new resolutions to current challenges and provide the patient perspective. Our belief that the best therapy is one that is determined by the patient and his/her doctor, inspires us to advocate for equitable and timely drug access.
I’m a Patient Leader